Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

Retinitis pigmentosa (RP) is a rare inherited condition that causes the gradual death of photoreceptors (light-sensing cells) ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Discover the fascinating phenomenon of bubble rings at UH Manoa's NARP. Learn about their formation, characteristics, and the science behind this captivating display. #BubbleRings #UHManoa #NARP ...

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; and over 50 genes underlying ...

Aim To develop a simple and easily applicable classification of disease severity in retinitis pigmentosa (RP). Methods This is a retrospective cross-sectional study. Visual acuity (VA), visual field ...

Stage V was “retinitis proliferans”, which was subdivided into V(a), retinitis proliferans, and V(b), the “vascular type” of retinitis proliferans, while stage VI was retinal detachment and “gross ...

"Verana Health’s Qdata Retinitis Pigmentosa offers valuable insights into disease progression, patient demographics, and treatment outcomes, enabling us to refine our clinical development ...